- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02585193
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is a body of evidence that has evaluated the effect of Weight Watchers, a commercially available weight loss program, on changes in body weight. The current investigation aims to add to this body of evidence by providing additional data on changes in body weight and enhance the current evidence-base in regards to evaluating other health-related outcomes.
There is no evidence that demonstrates whether or not the weight loss as a result of the Weight Watchers program elicits changes in health-related outcomes related to aerobic capacity, flexibility, functional fitness, sleep, and other psychological measures. Additionally, within a scientific research protocol, measures of adherence and satisfaction have not been evaluated. This study will evaluate these outcomes beyond weight changes achieved across the 24-week program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15261
- Physical Activity and Weight Management Research Center / University of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female over age 18. Set "soft quotas" on the number of male and female participants - The desire is to have a 90% female / 10% male split.
- With or without previous Weight Watchers experience. Set quota on the number of participants with previous Weight Watchers experience at 65%.
- Self reported height/weight resulting in a Body Mass Index (BMI) of 27 to 43 kg/m2 (will re-screen at facility).
- Self report that he/she feels the need to lose weight.
- Willing to discontinue any current over-the-counter (OTC) supplements not recommended/prescribed by physician, with the exception of multivitamins or other vitamin supplement.
- Willing to follow recommendations required by study protocol.
- Willing to include demographic information (e.g., ethnicity, income and education).
- Willing to participate in consumer surveys and focus groups as a part of the intervention.
- Use of a personal smartphone on a daily basis. For Android devices, must be version 4.4 (code: KitKat) or 5.0 (codename: Lollipop). For iPhones, must be iOS6 and above. Cannot accommodate Blackberry devices.
- The willingness and ability to navigate and use applications on their smartphone on a daily basis (minimum training will be provided).
- Reliable home WiFi access
Ability to commit to attending up to 27 study visits in approximately 26 weeks:
- Ability to commit (to best of their ability) to attending weekly meetings, 30-60 minutes in duration, at the same day and time each week for 24 consecutive weeks (daytime and evening options will be available).
- Ability to commit to up to 3 additional study visits at Weeks 0, 12, and 24, each approximately 90 minutes in duration, to complete assessments (height, weight, questionnaires, physical measures).
Exclusion Criteria:
- Participants that are currently following a commercial weight-loss program.
- Participants that have been involved in a related market research program within the last 6 months.
- Pregnant or nursing, or planning on becoming pregnant over the next 9 months.
- Recent weight loss of ≥ 5 kg in the previous 3 months.
- History of clinically diagnosed eating disorder.
- Orthopedic limitations preventing participation in regular physical activity.
- Untreated thyroid disease or > 1 change in dose or type of thyroid medication over previous 6 months.
Taking any prescription medication with known effects on appetite or weight.
*With the exception of subjects on a stable dose of SSRIs (Selective Serotonin Re-uptake Inhibitors) for 6 months.
- Taking oral steroids.
- Chronic/inflammatory gastrointestinal disorders (irritable bowel syndrome acceptable).
- Previous surgical procedure for weight loss.
- Major surgery within the previous 3 months.
- History of heart problems (e.g., angina, bypass surgery, MI, etc) within previous 3 months.
- Presence of implanted cardiac defibrillator or pacemaker.
- Uncontrolled hypertension self-reported BP > 160/100mmHg)
- Diuretic use for hypertension over 1.5mg per day
- Diagnosis of type 1 or type 2 diabetes
- History of presence of cancer (completely respected basal or squamous cell carcinoma acceptable if treatment completed more than 6 months prior to enrollment).
- Consuming more than 14 alcoholic drinks per week or not more than 3 drinks per day.
- Planning to relocate in the next 9 months
- Any orthopedic limitation preventing participation in regular physical activity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Weight Watchers Intervention
All participants are enrolled in this single arm of the study.
All participants receive the Weight Watchers intervention which consists of weekly group intervention/support meetings in which weight loss behaviors (diet, physical activity) are discussed.
|
All participants are enrolled in this single arm of the study.
All participants receive the Weight Watchers intervention which consists of weekly group intervention/support meetings in which weight loss behaviors (diet, physical activity) are discussed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Weight Change
Time Frame: 6 months
|
To examine the effect of a 24-week commercially available weight loss program on weight change.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sleep Quality and Duration
Time Frame: 6 months
|
Sleep quality and duration.
Participants will be asked to complete the Pittsburgh Sleep Quality Index (PSQI) at baseline, Months 3 and 6.
The PSQI is a validated self-report measure of sleep duration and sleep quality.
|
6 months
|
|
Change in Happiness
Time Frame: 6 months
|
Participants will be asked to complete the Oxford Happiness Questionnaire at baseline, Months 3 and 6.
The OHQ is a validated self-report measure for broad personal happiness.
Respondents rate 29 sentences on a 6 point Likert scale (1, strongly disagree; 6, strong agree).
|
6 months
|
|
Change in Food Cravings
Time Frame: 6 months
|
The Food Craving Inventory-II (FCI-II) is a validated self-report measure for general cravings and cravings for specific types of foods and will be completed at baseline, Months 3 and 6.
Respondents rate the frequency of cravings since the last time they completed the survey for each of 33 food items using a five-point Likert scale (1, never; 2, rarely; 3, sometimes; 4, often; 5, always/almost every day).
The FCI-II consists of 5 scales (sweets, high fats, carbohydrates/starches, fast food fats, and fruits & vegetables) that constitute the higher order construct of food cravings (the total score).
|
6 months
|
|
Program Satisfaction
Time Frame: 6 months
|
Program Satisfaction. Two parts to evaluate:
|
6 months
|
|
Program Adherence
Time Frame: 6 months
|
Data on adherence (attendance at meetings and use of the points system) will also be collected.
Attendance data will be recorded by Weight Watchers staff at every meeting.
These data will be confirmed by a member of the research staff that will be attending the weekly Weight Watchers meetings.
In addition, the weekly weights obtained at the intervention sessions will be provided to the investigators by the intervention staff to allow for examination of the trajectory of weight loss.
|
6 months
|
|
Change in Aerobic Capacity, Functional Fitness, Balance, Flexibility
Time Frame: 6 months
|
Aerobic Capacity: Participants will complete a 6 minute walk test on a designated walking course. The 6 minute walk test is a measure of functional and aerobic capacity. Participants will asked to walk at a brisk, yet comfortable pace for a total of 6 minutes. Functional Fitness and Balance: The Short Physical Performance Battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests to measure functional fitness. Flexibility: Lower body flexibility will be assessed through the sit and reach test. The sit and reach is a common test to measure lower back and lower body flexibility. This will be collected 3 times with the best of 3 scores utilized. |
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Renee J Rogers, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO15040047
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Weight Watchers Intervention
-
University of BirminghamNational Institute for Health Research, United KingdomUnknownIdiopathic Intracranial HypertensionUnited Kingdom
-
The Miriam HospitalCompleted
-
University of California, San FranciscoWithdrawnMorbid ObesityUnited States
-
University of PennsylvaniaWW International IncCompleted
-
University of ConnecticutWeight Watchers InternationalCompletedOverweight and Obesity
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of North Carolina, Chapel HillWeight Watchers InternationalCompletedOverweight and ObesityUnited States
-
Baruch College City University of New YorkNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesityUnited States
-
University of British ColumbiaCompleted
-
Indiana UniversityIndiana Clinical and Translational Sciences Institute; Weight Watchers International and other collaboratorsCompletedObesity | Prediabetes | Gestational Diabetes MellitusUnited States